ADAMS KENDRA (Chief Financial Officer) exercised options at C4 THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 9/19/2025ACC: 0001470831-25-000223
Officer· Chief Financial Officer
Since Feb 2026
+3.48K
Net shares
Net buyer
$9.2K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
6.25K acquired · 2.77K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
3.9%
9/18/2025
158.87K→165.12K
Common Stock
Direct
Shares
−2.77K
Price / share
$3.32
Trade value
$9.21K
% of position
1.7%
9/18/2025
165.12K→162.34K
Total
Net shares
+3.48K
Net value
-$9.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/18/2025 | M · Option Exercise | +6.25K | — | — | 3.9% | 158.87K | 165.12K |
| Common Stock Direct | 9/18/2025 | F · Tax Withholding | −2.77K | $3.32 | $9.21K | 1.7% | 165.12K | 162.34K |
| Total | +3.48K | -$9.21K | ||||||
Derivative Transactions0
No derivative transactions reported